We are live on ! Find out more
CV

Clarus Ventures Portfolio holdings

AUM $425M
1-Year Est. Return 26.13%
This Fund
S&P 500
This Quarter Est. Return
+19.99%
1 Year Est. Return
+26.13%
3 Year Est. Return
+70.29%
5 Year Est. Return
+162.11%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$14.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
10.6 quarters
Top 10 Avg Time Held
10.6 quarters
Top 20 Avg Time Held
10.6 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NSTG
1
DELISTED
NanoString Technologies, Inc.
NSTG
$64M 52.08%
3,959,440
– –
2013 Q4
15 quarters
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$42.1M 34.23%
273,077
– –
2014 Q4
11 quarters
VBIV icon
3
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$10.4M 8.43%
89,701
– –
2014 Q3
12 quarters
ATXS icon
4
DELISTED
Astria Therapeutics
ATXS
$5.83M 4.75%
45,875
– –
2015 Q2
9 quarters
EPIX icon
5
DELISTED
ESSA Pharma
EPIX
$615K 0.5%
106,061
– –
2016 Q1
6 quarters

Similar funds

LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
SPC
Salient Private Client Houston, Texas $513M AUM 10.97% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
CG
Clinton Group New York $279M AUM 4.76% 1-Year Est. Return
AAM
Amerigo Asset Management George Town, Cayman Islands $254M AUM 115.73% 1-Year Est. Return
SE
Summit Equities Parsippany, New Jersey $601M AUM 9.74% 1-Year Est. Return
CA
Cynosure Advisors Salt Lake City, Utah $238M AUM 4% 1-Year Est. Return

Clarus Ventures's Q3 2017 Portfolio in Review

As of Q3 2017, Clarus Ventures held 5 positions worth $123M, up 13% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 0%. Clarus Ventures opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Clarus Ventures's ten largest holdings make up 100% of its $123M portfolio in Q3 2017.
  • Clarus Ventures opened 0 new positions and closed 0 in Q3 2017.
  • Clarus Ventures's portfolio value rose 13% quarter-over-quarter to $123M.

Based on Clarus Ventures's 13F filing for Q3 2017, filed 13 Nov 2017.